Here are the 10-K annual reports from OrthoPediatrics Corp. (KIDS) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow KIDS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full KIDS filings page.
OrthoPediatrics Corp. reports strong expansion as a pediatric-focused medical device and bracing company, targeting a global pediatric orthopedic market it estimates at $6.2 billion, including over $2.8 billion in the United States.
The company markets 87 surgical and specialized bracing systems across trauma and deformity, scoliosis and sports medicine, and has grown revenue from $10.2 million in 2011 to $236.3 million in the year ended December 31, 2025, a 25.2% compound annual growth rate. For 2025, trauma and deformity generated $166.3 million (70% of revenue), scoliosis $66.0 million (28%), and sports medicine/other $4.0 million (2%).
The report highlights an active acquisition program, including the 2024 purchase of Boston Brace International, Inc. and multiple O&P clinic roll-ups in the United States, Europe and Brazil, alongside new technology partnerships and an expanded credit and convertible note structure with Braidwell. As of December 31, 2025, OrthoPediatrics had consolidated total assets of $508.6 million, liabilities of $162.0 million, stockholders’ equity of $346.6 million, and 602 full-time equivalent employees.